Posted on 3 月 9, 20233/9/23
2023 Greatest Creators Cover Competition Runners-Up
Posted on 3 月 9, 20233/9/23
PM360 Greatest Creators Showcase 2023 Selection EVERSANA INTOUCH
Posted on 3 月 7, 20233/7/23
SHORLA ONCOLOGY ANNOUNCES U.S. FDA APPROVAL OF NELARABINE INJECTION FOR THE TREATMENT OF T-CELL LEUKEMIA
Posted on 3 月 6, 20233/6/23
MM+M names 2023 classes of Women of Distinction, Women to Watch
Posted on 2 月 27, 20232/27/23
Xspray Pharma Partners with EVERSANA for the U.S. Launch and Commercialization of its Lead Product Dasynoc
Posted on 2 月 24, 20232/24/23
The Promise and Peril of ChatGPT in Healthcare and Pharma Marketing
Posted on 2 月 22, 20232/22/23
Q and A With Greg Skalicky, president and chief revenue officer of EVERSANA
Posted on 2 月 17, 20232/17/23
Can ChatGPT revolutionize pharma marketing?
Posted on 2 月 16, 20232/16/23
The Explosive Arrival of Chat GPT and Generative AI
Posted on 2 月 9, 20232/9/23